title: Calcitonin gene-related peptide stimulates human villous trophoblast cell differentiation in vitro.
abstract: Calcitonin gene-related peptide (CGRP) is a multifunctional peptide present in both maternal and fetal circulations in pregnancy. Its receptors have been identified on human trophoblast cells, but the role of CGRP in trophoblast differentiation remains unknown. This study was designed to determine the effect of CGRP on the differentiation of villous trophoblasts isolated from normal human term placentae. The morphological and functional differentiation of the trophoblast cells were assessed by desmosomal protein immunofluorescent staining and the quantification of hCG, estrogen and progesterone secretion. Results showed that (i) exposure of villous trophoblast cells to CGRP led to a dose-dependent increase in intracellular cyclic adenosine monophosphate (cAMP) accumulation; (ii) immunofluorescent staining with antidesmosomal antibody was identified at the boundaries between aggregated cytotrophoblast cells, and these stainings disappeared when cells fused to form syncytiotrophoblast cells; (iii) the formation of multinucleated syncytiums in primary cultured cytotrophoblasts was stimulated by CGRP as evidenced by the changes in antidesmosomal staining; (iv) CGRP increases trophoblast hCG secretion in a time- and dose-dependent manner, and this secretion was blocked by CGRP antagonist, CGRP(8-37), and (v) both 17beta-estradiol (E(2)) and progesterone concentrations in the culture medium were increased by CGRP, and these increases were dose dependent. These observations suggest that CGRP may be involved in the morphological and functional differentiation of trophoblast cells, and these actions might be attributed to CGRP-induced intracellular cAMP accumulation.
authors.affiliation: Department of Obstetrics and Gynecology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-1062, USA.
authors.forename: K E
authors.initials: KE
authors.lastname: Green
authors.forename: C
authors.initials: C
authors.lastname: Thota
authors.forename: G D V
authors.initials: GD
authors.lastname: Hankins
authors.forename: C
authors.initials: C
authors.lastname: Yallampalli
authors.forename: Yuan-Lin
authors.initials: YL
authors.lastname: Dong
mesh_terms: D015740:Calcitonin Gene-Related Peptide / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects*; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005260:Female; D005455:Fluorescent Antibody Technique; D015726:Giant Cells / Q000378:metabolism; D006801:Humans; D007633:Keratins / Q000378:metabolism; D010920:Placenta / Q000166:cytology / Q000378:metabolism; D011247:Pregnancy; D011257:Pregnancy Proteins / Q000378:metabolism; D018015:Receptors, Calcitonin Gene-Related Peptide / Q000737:chemistry / Q000378:metabolism; D013997:Time Factors; D014327:Trophoblasts / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism
chemical_list: D011257:Pregnancy Proteins; D018015:Receptors, Calcitonin Gene-Related Peptide; D007633:Keratins; D000242:Cyclic AMP; D015740:Calcitonin Gene-Related Peptide